SOX2 and head and neck squamous cell carcinoma: While PIK3CA amplifications have previously been reported in HPV+ HNSCC [40,41], SOX2 has recently been proposed as the critical target of 3q gains observed at a high frequency in squamous lung cancer [42] and in esophageal squamous cell carcinoma [43].